SCHEMBL3837337

SCHEMBL3837337

CCOc1cccc(OCc2c(C)nc(-c3c(C)cccc3C)nc2N2CCN(CC(N)=O)[C@H](C)C2)c1.Cc1cccc(C)c1-c1nc(C)c(COc2cccc(OC(C)C)c2)c(N2CCN(CC(N)=O)[C@H](C)C2)n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 7/20 0.43
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 2/20 0.35
ACACB O00763 4/20 0.34
ACACA Q13085 3/20 0.34
NPSR1 Q6W5P4 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
USP2 O75604 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
KDM4E B2RXH2 1/20 0.33
KIT P10721 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62759 0.97 C5AR1 (0.44) C5AR1ALDH1A1SMN1; SMN2LMNAACACB
SCHEMBL61134 0.95 C5AR1 (0.42) C5AR1ALDH1A1SMN1; SMN2LMNAACACB
SCHEMBL62072 0.82 C5AR1 (0.54) C5AR1MEN1KMT2A
SCHEMBL62140 0.82 C5AR1 (0.54) C5AR1MEN1KMT2A
SCHEMBL61195 0.82 C5AR1 (0.43) C5AR1MEN1KMT2APKM
SCHEMBL62818 0.82 C5AR1 (0.46) C5AR1
SCHEMBL64888 0.81 C5AR1 (0.44) C5AR1MEN1KMT2AKIT
SCHEMBL62870 0.81 C5AR1 (0.48) C5AR1KIT
SCHEMBL61219 0.81 C5AR1 (0.44) C5AR1
SCHEMBL61199 0.80 C5AR1 (0.43) C5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745033-A4 4,5-DISUBSTITUTED-2-ARYL PYRIMIDINES NEUROGEN CORP (US) 2009-08-26 EP claimed
EP-1745033-A2 4,5-DISUBSTITUTED-2-ARYL PYRIMIDINES NEUROGEN CORPORATION (US) 2007-01-24 EP claimed
WO-2005110416-A2 4,5-DISUBSTITUTED-2-ARYL PYRIMIDINES NEUROGEN CORPORATION (US) 2005-11-24 WO claimed